Salt and crystal form of PARG inhibitor, and composition, preparation method, and use thereof

TW202629195APending Publication Date: 2026-07-16BEIJING DANQING PHARM TECH CO LTD

0 Cites 0 Cited by

Patent Information

Application Number: TW114139734
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2025-10-15
Publication Date: 2026-07-16

Application Information

Patent Timeline

15 Oct 2025

Application

TW114139734

16 Jul 2026

Publication

TW202629195A

IPC: A61K31/519; A61K31/4155; A61K31/44; A61P35/00

Inventors: 周文來; 卓金聰

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a salt, and a crystal form of a compound of formula (I), a composition comprising the same, a preparation method and use. The salt and crystal form of the compound of formula (I) in the present invention can effectively inhibit a disease mediated by PARG, such as cancer and the like.

Need to check novelty before this filing date? Find Prior Art